Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Intensification in Ewing's Sarcoma
NCT00006734Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- May 2001
- Primary completion
- Aug 2006
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 7
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection, pegylated liposomal doxorubicin, cyclophosphamide, ifosfamide, etoposide in Ewing sarcoma, primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Started May 2001; status: completed.
02
Drugs
vincristine sulfate liposome injectionpegylated liposomal doxorubicincyclophosphamideifosfamideetoposide
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00006734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006734.